Results 371 to 380 of about 1,471,327 (421)

Methotrexate for induction of remission in ulcerative colitis

2007
Ulcerative colitis is a chronic inflammatory bowel disease. Corticosteroids and 5-aminosalicylates are the most commonly used therapies. However, many patients require immunosuppressive therapy when their disease becomes steroid-refractory or dependent.
N, Chande, J K, MacDonald, J W D, McDonald   +2 more
openaire   +2 more sources

INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICIN

The Lancet, 1978
Doxorubicin (60 mg/m2 at 3-weekly intervals to a maximum total of 550 mg/m2) induced clinical remission in 14 (32%) of 44 patients with hepatocellular carcinoma. In 3 of those who responded, hepatic arteriography showed clearing of the previously extensive tumour circulation, and in a 4th there was disappearance of the tumour on serial ultrasound ...
Roger Williams, Roger Williams, Roger Williams, Sheila Sherlock, Sheila Sherlock, Sheila Sherlock, Philip J. Johnson, Philip J. Johnson, Philip J. Johnson, Howard Thomas, Howard Thomas, Howard Thomas, I. M. Murray-Lyon, I. M. Murray-Lyon, I. M. Murray-Lyon   +14 more
openaire   +3 more sources

Cyclosporine for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews, 2005
Cyclosporine was first found to be an effective and well-tolerated immunosuppressive agent in organ transplant recipients, and subsequently in several autoimmune diseases. It was reported in open studies that cyclosporine is effective for induction of remission in Crohn's disease.
John K MacDonald, Derek P. Jewell, Brian G. Feagan, Eduard F. Stange, John W.D. McDonald, Jørn Brynskov   +5 more
openaire   +3 more sources

Probiotics for induction of remission in ulcerative colitis

2006
Ulcerative Colitis (UC) is an inflammatory condition affecting the colon with an incidence of approximately 10-20 per 100,000 per year. No existing intervention is effective in all patients with a proportion requiring colectomy. There are significant proportion of patients who experience adverse effects with current therapies.
Keith Gardiner, Damian McKay, Steven J Kirk, Peter T Mallon   +3 more
openaire   +3 more sources

Budesonide for induction of remission in Crohn's disease

1996
Corticosteroids continue to play a central role in induction of remission in active Crohn's disease. However, their use comes at a price of significant adverse effects when used repeatedly or for extended periods. Newer corticosteroid agents with limited systemic bioavailability offer a tantalizing option, if they can be shown to be efficacious and ...
A, Otley, A H, Steinhart
openaire   +2 more sources

Induction of remission in rheumatoid arthritis: criteria and opportunities

Rheumatology International, 2008
The concept of remission in rheumatology is complicated by the lack of a single gold standard measurement, spontaneous remissions and the usage of several sets of remission criteria. Feasibility is reduced by traditional clinical practice, which does not include remission criteria monitoring.
VALESINI, Guido, DI FRANCO, Manuela, SPINELLI, FRANCESCA ROMANA, SCRIVO, Rossana   +3 more
openaire   +4 more sources

Fish oil for induction of remission in ulcerative colitis

Cochrane Database of Systematic Reviews, 2006
Fish oil supplements, which are rich in n-3 fatty acids, may reduce inflammation, decrease the need for anti-inflammatory drugs, and promote normal weight gain in people with ulcerative colitis.This review evaluates the efficacy of fish oil for induction of remission in ulcerative colitis using all available randomised controlled trials.The Cochrane ...
Daniel W Hommes, Maartje de Ley, Pieter C. F. Stokkers, Rien de Vos   +3 more
openaire   +3 more sources

Budesonide for induction of remission in Crohn's disease

2008
Corticosteroids play a key role in the induction of remission in Crohn's disease. However, corticosteroids can cause significant adverse events. Budesonide is an alternate enteral glucocorticoid with limited systemic bioavailability.The primary objective was to evaluate the efficacy and safety of oral budesonide for the induction of remission in Crohn ...
Cynthia H, Seow, Eric I, Benchimol, Anne Marie, Griffiths, Anthony R, Otley, A Hillary, Steinhart   +4 more
openaire   +2 more sources

Transdermal nicotine for induction of remission in ulcerative colitis

Cochrane Database of Systematic Reviews, 2004
Ulcerative colitis is largely a disease of nonsmokers. Intermittent smokers often experience improvement in their symptoms while smoking. Nonsmokers with ulcerative colitis who begin smoking may go into remission. Randomized controlled trials were developed to test the efficacy of transdermal nicotine for the induction of remission in ulcerative ...
John K MacDonald, John Wd McDonald, Jerry McGrath   +2 more
openaire   +3 more sources

Methotrexate for induction of remission in refractory Crohn's disease

2002
Although corticosteroids are effective for induction of remission of Crohn's disease, approximately 20% of patients who respond relapse when steroids are withdrawn and become steroid dependent (Binder 1985). Furthermore, corticosteroids exhibit significant adverse effects.
A A, Alfadhli, J W, McDonald, B G, Feagan   +2 more
openaire   +3 more sources